Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Gaynon

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 1, 1997
Acute lymphoblastic leukaemia: a guide to asparaginase and pegaspargase therapyL J Ettinger, A G Ettinger, V I Avramis, et al.
Medical and Pediatric Oncology|July 1, 1997
Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukemiaK R Schultz, B Massing, J J Spinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer GroupJ Nachman, H N Sather, P S Gaynon, et al.
Leukemia & Lymphoma|June 28, 2001
Bone marrow leukemic progenitor cell content in pediatric T-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapseF M Uckun, P S Gaynon, D O Stram, et al.
Cancer|July 15, 1997
A phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow: a report of the Children's Cancer GroupL J Ettinger, P Ivy, P S Gaynon, et al.
Cancer|December 15, 1990
Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trialP S Gaynon, L J Ettinger, E S Baum, et al.
Leukemia & Lymphoma|November 9, 2001
Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemiaF M Uckun, N Pallisgaard, P Hokland, et al.
Cancer Treatment Reports|November 1, 1987
Pediatric phase I trial of carboplatin: a Childrens Cancer Study Group reportP S Gaynon, L J Ettinger, D Moel, et al.
Cancer|February 15, 1994
A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer GroupL J Ettinger, P S Gaynon, M D Krailo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Paucity of leukemic progenitor cells in the bone marrow of pediatric B-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapseF M Uckun, P S Gaynon, D O Stram, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 1, 1997
Acute lymphoblastic leukaemia: a guide to asparaginase and pegaspargase therapyL J Ettinger, A G Ettinger, V I Avramis, et al.
Medical and Pediatric Oncology|July 1, 1997
Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukemiaK R Schultz, B Massing, J J Spinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer GroupJ Nachman, H N Sather, P S Gaynon, et al.
Leukemia & Lymphoma|June 28, 2001
Bone marrow leukemic progenitor cell content in pediatric T-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapseF M Uckun, P S Gaynon, D O Stram, et al.
Cancer|July 15, 1997
A phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow: a report of the Children's Cancer GroupL J Ettinger, P Ivy, P S Gaynon, et al.
Cancer|December 15, 1990
Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trialP S Gaynon, L J Ettinger, E S Baum, et al.
Leukemia & Lymphoma|November 9, 2001
Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemiaF M Uckun, N Pallisgaard, P Hokland, et al.
Cancer Treatment Reports|November 1, 1987
Pediatric phase I trial of carboplatin: a Childrens Cancer Study Group reportP S Gaynon, L J Ettinger, D Moel, et al.
Cancer|February 15, 1994
A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer GroupL J Ettinger, P S Gaynon, M D Krailo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Paucity of leukemic progenitor cells in the bone marrow of pediatric B-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapseF M Uckun, P S Gaynon, D O Stram, et al.
Pageof 7